Select Page

GW Pharmaceuticals has revealed the expected consumer price for Epidiolex, the first cannabidiol-based medication to be approved by the FDA, according to a Business Insider report. At a price tag of about $32,500 per year, it won’t be cheap, but company representatives said in a phone call with investors this week that its cost reflects that of […]

Continue reading…

Trending stories from over 100 sources, YouTube and Twitter
Our archive contains 22,562 news items. 486 articles added this week.